NCT00915187View on ClinicalTrials.gov

Safety and Immunogenicity Study of Intramuscular CCS/C-adjuvanted Influenza Vaccine in Elderly

PHASE2CompletedINTERVENTIONAL

Enrollment

130

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

February 28, 2010

Conditions

Influenza

Interventions

DRUG

CCS/C

Adjuvant to influenza vaccine

BIOLOGICAL

Influenza Vaccine

Influenza vaccine

Trial Locations (1)

91120

Clinical Pharmacology Unit, Division of Medicine, Hadassah University Hospital, Jerusalem

Sponsors

Lead Sponsor

All Listed Sponsors

lead

NasVax Ltd

INDUSTRY